Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Carl Marks & Co. is a leading middle-market investment bank and financial advisory firm that has been in operation since 1925. The firm specializes in providing a wide array of services, including mergers and acquisitions, corporate restructuring, and strategic capital advisory. While not a life sciences company itself, Carl Marks & Co. maintains a dedicated healthcare industry group that focuses on the financial and operational needs of healthcare providers, medical technology firms, and pharmaceutical services companies. The firm is particularly well-known for its expertise in distressed situations and complex financial reorganizations within the healthcare sector. Headquartered in New York, it serves a global client base through its various advisory and investment arms. As a private, family-owned entity, it provides tailored financial solutions to companies navigating significant transitions or growth phases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Carl Marks & Co..